By Alnylam Pharmaceuticals | July 13, 2017Alnylam & Sanofi Report Positive Results from Phase 2 Study of Fitusiran
By Alnylam Pharmaceuticals | June 27, 2017New Positive Clinical Results for Givosiran in Acute Intermittent Porphyria Patients with Recurrent Attacks
